Boston Scientific Corp (NYSE:BSX) — Stock Price
Boston Scientific Corp (NYSE:BSX) is currently trading at $50.46 USD, up 2.33% today. Over the past 52 weeks, shares have ranged between $42.63 and $108.14. This page tracks Boston Scientific Corp's live share price on the NYSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of Boston Scientific Corp.
Boston Scientific Corp (BSX) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Boston Scientific Corp's daily closing share price and trading volume on the NYSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Boston Scientific Corp Income Statement — Revenue, Profit & Earnings by Year
Boston Scientific Corp's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $20.07 Billion | $16.75 Billion | $14.24 Billion | $12.68 Billion | $11.89 Billion |
| Cost of Revenue | $6.22 Billion | $6.48 Billion | $5.41 Billion | $4.97 Billion | $4.43 Billion |
| Gross Profit | $13.85 Billion | $10.27 Billion | $8.83 Billion | $7.71 Billion | $7.46 Billion |
| Research & Development | $2.05 Billion | $1.61 Billion | $1.41 Billion | $1.32 Billion | $1.20 Billion |
| SG&A | $6.89 Billion | $5.98 Billion | $4.97 Billion | $4.52 Billion | $4.36 Billion |
| Total Operating Expenses | $9.88 Billion | $7.63 Billion | $6.65 Billion | $5.89 Billion | $5.54 Billion |
| Operating Income | $3.97 Billion | $2.63 Billion | $2.18 Billion | $1.82 Billion | $1.92 Billion |
| EBITDA | $3.73 Billion | $3.94 Billion | $3.45 Billion | $2.74 Billion | $2.52 Billion |
| EBIT | — | $2.67 Billion | $2.26 Billion | $1.60 Billion | $1.43 Billion |
| Interest Expense | $349.00 Million | $387.00 Million | $272.00 Million | $464.00 Million | $349.00 Million |
| Income Before Tax | $3.38 Billion | $2.28 Billion | $1.99 Billion | $1.14 Billion | $1.08 Billion |
| Income Tax Expense | $493.00 Million | $436.00 Million | $393.00 Million | $443.00 Million | $36.00 Million |
| Net Income | $2.89 Billion | $1.85 Billion | $1.59 Billion | $698.00 Million | $1.04 Billion |
Boston Scientific Corp Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Boston Scientific Corp's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $43.67 Billion | $39.40 Billion | $35.14 Billion | $32.47 Billion | $32.23 Billion |
| Total Current Assets | $8.79 Billion | $6.92 Billion | $6.51 Billion | $5.76 Billion | $6.32 Billion |
| Cash & Equivalents | $1.97 Billion | $414.00 Million | $865.00 Million | $928.00 Million | $1.93 Billion |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | $2.93 Billion | $2.56 Billion | $2.23 Billion | $1.97 Billion | $1.78 Billion |
| Inventory | $2.94 Billion | $2.81 Billion | $2.48 Billion | $1.87 Billion | $1.61 Billion |
| Property, Plant & Equipment | $4.50 Billion | $3.74 Billion | $3.30 Billion | $2.83 Billion | $2.25 Billion |
| Goodwill | $18.28 Billion | $17.09 Billion | $14.39 Billion | $12.92 Billion | $11.99 Billion |
| Total Liabilities | $19.20 Billion | $17.39 Billion | $15.61 Billion | $14.90 Billion | $15.61 Billion |
| Total Current Liabilities | $5.44 Billion | $6.40 Billion | $4.93 Billion | $3.80 Billion | $4.27 Billion |
| Long-term Debt | $11.14 Billion | $8.84 Billion | $8.57 Billion | $8.91 Billion | $8.79 Billion |
| Net Debt | $10.37 Billion | $10.73 Billion | $8.63 Billion | $8.35 Billion | $7.53 Billion |
| Total Stockholder Equity | $24.23 Billion | $21.77 Billion | $19.28 Billion | $17.57 Billion | $16.62 Billion |
| Retained Earnings | $5.57 Billion | $2.67 Billion | $819.00 Million | $-750.00 Million | $-1.39 Billion |
Boston Scientific Corp Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Boston Scientific Corp generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | $4.53 Billion | $3.44 Billion | $2.50 Billion | $1.53 Billion | $1.87 Billion |
| Capital Expenditures | $876.00 Million | $790.00 Million | $800.00 Million | $612.00 Million | $554.00 Million |
| Free Cash Flow | $3.66 Billion | $2.65 Billion | $1.70 Billion | $914.00 Million | $1.32 Billion |
| Investing Cash Flow | $-2.64 Billion | $-5.69 Billion | $-2.57 Billion | $-2.01 Billion | $-1.60 Billion |
| Financing Cash Flow | $-395.00 Million | $1.81 Billion | $5.00 Million | $-548.00 Million | $-95.00 Million |
| Dividends Paid | — | $0.00 | $28.00 Million | $55.00 Million | $55.00 Million |
| Stock-Based Compensation | $299.00 Million | $266.00 Million | $233.00 Million | $220.00 Million | $194.00 Million |
| Depreciation | $1.37 Billion | $1.27 Billion | $1.20 Billion | $1.14 Billion | $1.09 Billion |
| Change in Cash | $1.54 Billion | $-449.00 Million | $-82.00 Million | $-1.04 Billion | $173.00 Million |
Boston Scientific Corp Earnings History — EPS Actual vs. Analyst Estimates
Track Boston Scientific Corp's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Jul 29, 2026 | — | 0.83 | — |
| Apr 22, 2026 | 0.80 | 0.79 | +1.27% |
| Feb 04, 2026 | 0.80 | 0.78 | +2.56% |
| Oct 22, 2025 | 0.75 | 0.71 | +5.63% |
| Jul 23, 2025 | 0.75 | 0.73 | +2.74% |
| Apr 23, 2025 | 0.75 | 0.67 | +11.94% |
| Feb 05, 2025 | 0.70 | 0.66 | +6.06% |
| Oct 23, 2024 | 0.63 | 0.59 | +6.78% |